Ontology highlight
ABSTRACT:
SUBMITTER: Morein-Zamir S
PROVIDER: S-EPMC2779875 | biostudies-literature | 2007 Nov
REPOSITORIES: biostudies-literature
Schizophrenia bulletin 20070718 6
Modafinil, a wake-promoting agent believed to operate via the hypocretin/orexin system, has a similar clinical profile to that of conventional, dopaminergic stimulants but different biochemical and pharmacological properties. There is increasing interest in the use of modafinil to improve cognition in schizophrenia as well as in other disorders such as attention-deficit/hyperactivity disorder. Recent research has focused on enhancing cognition in patients with schizophrenia because of the associ ...[more]